Does ELRANATAMAB-BCMM Cause Off label use? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Off label use have been filed in association with ELRANATAMAB-BCMM. This represents 4.7% of all adverse event reports for ELRANATAMAB-BCMM.
27
Reports of Off label use with ELRANATAMAB-BCMM
4.7%
of all ELRANATAMAB-BCMM reports
2
Deaths
10
Hospitalizations
How Dangerous Is Off label use From ELRANATAMAB-BCMM?
Of the 27 reports, 2 (7.4%) resulted in death, 10 (37.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELRANATAMAB-BCMM. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does ELRANATAMAB-BCMM Cause?
Cytokine release syndrome (115)
Death (51)
Pyrexia (46)
Fatigue (31)
Neoplasm progression (31)
Cytomegalovirus infection reactivation (29)
Malignant neoplasm progression (27)
Immune effector cell-associated neurotoxicity syndrome (26)
Infection (25)
Cytomegalovirus infection (20)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ELRANATAMAB-BCMM Alternatives Have Lower Off label use Risk?
ELRANATAMAB-BCMM vs ELTROMBOPAG
ELRANATAMAB-BCMM vs ELTROMBOPAG OLAMINE
ELRANATAMAB-BCMM vs ELUXADOLINE
ELRANATAMAB-BCMM vs ELVITEGRAVIR
ELRANATAMAB-BCMM vs EMAPALUMAB